Christian Angermayer bought $23M of ATAI
director, owner at Atai Beckley N.V.. 10,835,718 shares at an average of $2.10, traded Feb 14, 2025, filed Feb 19, 2025.
Score components
- +15RoleDirector
- +25Trade size$22.8M at market
- +6Relative to holdingsHoldings up 36%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-023436, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | POpen-market purchase Common Sharesindirect: By Apeiron Investment Group Ltd. | +10,835,718 | $2.10 | $23M | 40,555,215 | Feb 19, 2025 |
Related signals
Other insiders at Atai Beckley N.V. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ATAIbuy Atai Beckley N.V. | Christian Angermayer director, owner | $19M 8,675,799 shares | +20% | |
| 45Moderate | ATAIbuy Atai Beckley N.V. | Christian Angermayer director, owner | $2.5M 1,800,000 shares | +4% | |
| 35Weak | Atai Beckley N.V. | Glenn Frank Short Chief Scientific Officer | $18k 13,161 shares | -24% | |
| 48Moderate | Atai Beckley N.V. | Anne Nagengast Johnson Chief Financial Officer | $45k 33,545 shares | -19% | |
| 50Moderate | Atai Beckley N.V. | Srinivas Rao See Remarks | $102k 75,418 shares | -26% | |
| 50Moderate | Atai Beckley N.V. | Kevin James Craig Chief Medical Officer | $16k 11,563 shares | -58% | |
| 48Moderate | Atai Beckley N.V. | Sahil Kirpekar Chief Business Officer | $66k 48,563 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.